Author
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteORCID 0000-0002-2054-5206Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Marco A. Rodriguez, Hemamylammal Sivakumar, Liudmila V. Popova…·Aleksander Skardal
This paper develops patient-derived ACC tumor constructs to evaluate therapeutic strategies, showing they can test chemotherapies, targeted therapies, and immunotherapies.
Joseph Mills, Anna Tessari, Vollter Anastas…·Dario Palmieri
This study uses the AID system with CRISPR/Cas9 to acutely degrade nucleolin in TNBC cells, revealing its role in cell cycle progression and division, and showing that its abrogation enhances the efficacy of mitotic inhibitors.
Marina Capece, Anna Tessari, Joseph Mills…·Carlo Maria Croce
The paper introduces a new AID system that enables cell cycle-specific protein degradation, allowing study of protein roles in specific cell cycle phases.
Jalal Siddiqui, Wayne O. Miles
The paper identifies RNA editing signatures that predict immunotherapy response in melanoma patients with high accuracy.
Dario Palmieri, Amanda Javorina, Jalal Siddiquii…·Wayne O. Miles
REMBRANDT is a high-throughput sequencing method for rapid SARS-CoV-2 screening, capable of processing over 100,000 samples per day.